(Updated - November 30, 2021 7:44 AM EST)Jefferies analyst Dennis Ding downgraded Sigilon Therapeutics (NASDAQ: SGTX) from Buy to Hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE